Synergistic antileukemic effects between ABT-869 and chemotherapy involve downregulation of cell cycle-regulated genes and c-Mos-mediated MAPK pathway

10.1038/sj.leu.2404960

Saved in:

Bibliographic Details
Main Authors:	Zhou, J., Pan, M., Xie, Z., Loh, S.-L., Bi, C., Tai, Y.-C., Lilly, M., Lim, Y.-P., Han, J.-H., Glaser, K.B., Albert, D.H., Davidsen, S.K., Chen, C.-S.
Other Authors:	NATIONAL UNIVERSITY MEDICAL INSTITUTES
Format:	Article
Published:	2014
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/108562
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-108562
record_format	dspace
spelling	sg-nus-scholar.10635-1085622023-10-29T22:31:17Z Synergistic antileukemic effects between ABT-869 and chemotherapy involve downregulation of cell cycle-regulated genes and c-Mos-mediated MAPK pathway Zhou, J. Pan, M. Xie, Z. Loh, S.-L. Bi, C. Tai, Y.-C. Lilly, M. Lim, Y.-P. Han, J.-H. Glaser, K.B. Albert, D.H. Davidsen, S.K. Chen, C.-S. NATIONAL UNIVERSITY MEDICAL INSTITUTES MEDICINE 10.1038/sj.leu.2404960 Leukemia 22 1 138-146 LEUKE 2014-11-25T09:47:36Z 2014-11-25T09:47:36Z 2008-01 Article Zhou, J., Pan, M., Xie, Z., Loh, S.-L., Bi, C., Tai, Y.-C., Lilly, M., Lim, Y.-P., Han, J.-H., Glaser, K.B., Albert, D.H., Davidsen, S.K., Chen, C.-S. (2008-01). Synergistic antileukemic effects between ABT-869 and chemotherapy involve downregulation of cell cycle-regulated genes and c-Mos-mediated MAPK pathway. Leukemia 22 (1) : 138-146. ScholarBank@NUS Repository. https://doi.org/10.1038/sj.leu.2404960 08876924 http://scholarbank.nus.edu.sg/handle/10635/108562 000252388400018 Scopus
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
description	10.1038/sj.leu.2404960
author2	NATIONAL UNIVERSITY MEDICAL INSTITUTES
author_facet	NATIONAL UNIVERSITY MEDICAL INSTITUTES Zhou, J. Pan, M. Xie, Z. Loh, S.-L. Bi, C. Tai, Y.-C. Lilly, M. Lim, Y.-P. Han, J.-H. Glaser, K.B. Albert, D.H. Davidsen, S.K. Chen, C.-S.
format	Article
author	Zhou, J. Pan, M. Xie, Z. Loh, S.-L. Bi, C. Tai, Y.-C. Lilly, M. Lim, Y.-P. Han, J.-H. Glaser, K.B. Albert, D.H. Davidsen, S.K. Chen, C.-S.
spellingShingle	Zhou, J. Pan, M. Xie, Z. Loh, S.-L. Bi, C. Tai, Y.-C. Lilly, M. Lim, Y.-P. Han, J.-H. Glaser, K.B. Albert, D.H. Davidsen, S.K. Chen, C.-S. Synergistic antileukemic effects between ABT-869 and chemotherapy involve downregulation of cell cycle-regulated genes and c-Mos-mediated MAPK pathway
author_sort	Zhou, J.
title	Synergistic antileukemic effects between ABT-869 and chemotherapy involve downregulation of cell cycle-regulated genes and c-Mos-mediated MAPK pathway
title_short	Synergistic antileukemic effects between ABT-869 and chemotherapy involve downregulation of cell cycle-regulated genes and c-Mos-mediated MAPK pathway
title_full	Synergistic antileukemic effects between ABT-869 and chemotherapy involve downregulation of cell cycle-regulated genes and c-Mos-mediated MAPK pathway
title_fullStr	Synergistic antileukemic effects between ABT-869 and chemotherapy involve downregulation of cell cycle-regulated genes and c-Mos-mediated MAPK pathway
title_full_unstemmed	Synergistic antileukemic effects between ABT-869 and chemotherapy involve downregulation of cell cycle-regulated genes and c-Mos-mediated MAPK pathway
title_sort	synergistic antileukemic effects between abt-869 and chemotherapy involve downregulation of cell cycle-regulated genes and c-mos-mediated mapk pathway
publishDate	2014
url	http://scholarbank.nus.edu.sg/handle/10635/108562
_version_	1781788537907052544

Synergistic antileukemic effects between ABT-869 and chemotherapy involve downregulation of cell cycle-regulated genes and c-Mos-mediated MAPK pathway

Similar Items